News summaryPR NewswireNov 12, 2026, 12:00 AM
Regal Intel Receives Two Seed Grants to Test Rare Disease Surveillance Guidelines Against Real Patient Outcomes
Regal Intel Receives Two Seed Grants to Test Rare Disease Surveillance Guidelines Against Real Patient Outcomes(摘要待生成)